Article
Here are my highlights from day three, Sunday, of the ACR 2020 Convergence.
All News
Article
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Article
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Listen here:
Dr. John Cush
Tweet
Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD consult) or appts. These observations show we were not prepared for this and that Rx suffered. #ACR20 Abstr#L05 https://t.co/vrDd0myGos https://t.co/JFUXItVdRQ
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the annual #ACR20 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush
Tweet
Deucravacitinib is a novel Tyrosine kinase 2 (TYK2) prev shown efficacy in psoriasis, now effective in PsA. PhII trial of 203 PsA patients showed wk 16 significant improvement in ACR20/50/70, enthesitis, SPARC scores. #ACR20 Abstr#L03 https://t.co/LGokmmlyrc
Janet Pope
Tweet
Intra-articulations steroids for the knee OA- finding benefits again! IA steroids were good then villified in press with accelerated cartilage loss. Pendulum swings back in abstr#1649 where quadriceps & gait improve post injection @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/0bRsiEKsW4
Richard Conway
Tweet
Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greater improvement in PROs with upadacitinib especially in physical functioning, pain, and general health @rheumnow #ACR20 Abstr#1728 https://t.co/NWKrhYAfZn
Dr. Rachel Tate
Tweet
@wendycostello2 @psufka @RheumNow Here's the only abstract that I could find from #ACR20 regarding telemed in pedi rheum clinics. https://t.co/yun6QCv4fX It doesn't answer your question but it may be helpful to consider follow up with the authors.
Eric Dein
Tweet
Evidence earlier in #ACR20 showed pts can give good reported jt scores. But PT globals, and evaluator globals, do not predict radiographic progression. MBDA does predict progression @LCalabreseDO @MeralElRamahiMD @RheumNow Abst#1730 https://t.co/YPWOqTRqV6
David Liew
Tweet
Tocilizumab in GCA: what happens in the vessels?
Supporting excellent work @KQuinnRheum @petercgrayson earlier at #ACR20, LV-GCA data from Blanco/Gonzalez-Gay et al. Aorta still hot at 10.8±3.7 mo.
in LV-GCA on TCZ, clinical remission ≠ PET remission
#ACR20 ABST1921 @RheumNow https://t.co/ngBVL4rop8
Richard Conway
Tweet
Will vagal nerve stimulation be clinically utilised? #ACR20 @rheumnow Abstr#1995
Dr. John Cush
Tweet
Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp
Mrinalini Dey
Tweet
High #bloodpressure, jaw claudication and temporal artery abnormalities on palpation associated with increased risk of serious ischaemic events in #GCA, incl visual loss and #CVA. #MSK symptoms including PMR are protective.
Abs#1944 #ACR20 @RheumNow
https://t.co/sTeql8py9r
Dr. Rachel Tate
Tweet
@psufka @wendycostello2 @RheumNow I love seeing patients in person! However, being pregnant during COVID19 made me adjust my practice significantly (as we all did.) Watch https://t.co/99R5rPryui it helped me to visualize the PE in an entirely new way. @RheumNow
Robert B Chao, MD
Tweet
Abs#1562 Detected subclinical synovitis/tenosynovitis in 37.2% of PsA pts in clinical remission. Do you routinely use MRI to monitor disease activity in your PsA patients? @RheumNow #ACR20
Eric Dein
Tweet
SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA
k dao
Tweet
Very young rheum patients (<21 y.o) may have higher risk for preterm delivery compared to those 21-25 y.o
Abstr#1762 #ACR20 @rheumnow
https://t.co/NyLEan2sA1
Meral K. El Ramahi, MD
Tweet
Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory back pain when trying to determine if a pt has SpA? Check out Abst1535 at #ACR20 for more thoughts on this. @RheumNow @ElaineHusniMD
sheila
Tweet
Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (<20ng/mL) is associated w/ renal insufficiency in SLE
🚨Levels >60ng/mL can ⬆renal insufficiency
This reinforces benefits of Vit.D supplementation (⬇ protnuria; immunomodulation)
@RheumNow #ACR20 abs1789 https://t.co/BJciK77fcp
